Skip to main content
Journal of the Egyptian National Cancer Institute
Fig. 1 | Journal of the Egyptian National Cancer Institute

Fig. 1

From: Patient characteristics and outcome of CD20-positive HIV-associated lymphoma: a single-center KwaZulu-Natal, South African hospital 12-year retrospective review

Fig. 1

Treatment, response, and 2-year outcome in CD 20 positive HAL

Abbreviations: CHOP cyclophosphamide, doxorubicin, vincristine, prednisone, R rituximab, CR complete response, PR partial response, LTFU lost to follow up, OS overall survival. *10 patients had CT scans and 74 patients had PET-CT scans at mid-cycle re-staging. ^6 patients received 2nd line chemotherapy and/or radiotherapy. ±10 patients received 2nd line chemotherapy

Back to article page